vs
Side-by-side financial comparison of TriSalus Life Sciences, Inc. (TLSI) and UNITED SECURITY BANCSHARES (UBFO). Click either name above to swap in a different company.
UNITED SECURITY BANCSHARES is the larger business by last-quarter revenue ($13.5M vs $13.2M, roughly 1.0× TriSalus Life Sciences, Inc.). UNITED SECURITY BANCSHARES runs the higher net margin — 25.2% vs -73.9%, a 99.1% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 13.6%). UNITED SECURITY BANCSHARES produced more free cash flow last quarter ($19.8M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 3.0%).
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
United Security Bancshares is a bank holding company headquartered in Fresno, California. It operates 11 branches.
TLSI vs UBFO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.2M | $13.5M |
| Net Profit | $-9.8M | $3.4M |
| Gross Margin | 86.7% | — |
| Operating Margin | -24.8% | 31.5% |
| Net Margin | -73.9% | 25.2% |
| Revenue YoY | 59.8% | 13.6% |
| Net Profit YoY | 3.5% | 36.8% |
| EPS (diluted) | $-0.22 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.2M | $13.5M | ||
| Q3 25 | $11.6M | $14.0M | ||
| Q2 25 | $11.2M | $12.6M | ||
| Q1 25 | $9.2M | $13.7M | ||
| Q4 24 | $8.3M | $11.9M | ||
| Q3 24 | $7.3M | $13.8M | ||
| Q2 24 | $7.4M | $13.0M | ||
| Q1 24 | $6.5M | $12.8M |
| Q4 25 | $-9.8M | $3.4M | ||
| Q3 25 | $-10.8M | $4.0M | ||
| Q2 25 | $-8.3M | $2.2M | ||
| Q1 25 | $-10.4M | $2.7M | ||
| Q4 24 | $-10.1M | $2.5M | ||
| Q3 24 | $-2.4M | $3.8M | ||
| Q2 24 | $-4.3M | $4.3M | ||
| Q1 24 | $-13.2M | $4.2M |
| Q4 25 | 86.7% | — | ||
| Q3 25 | 83.5% | — | ||
| Q2 25 | 83.9% | — | ||
| Q1 25 | 83.7% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 86.3% | — | ||
| Q2 24 | 87.6% | — | ||
| Q1 24 | 85.0% | — |
| Q4 25 | -24.8% | 31.5% | ||
| Q3 25 | -77.9% | 40.3% | ||
| Q2 25 | -65.4% | 24.0% | ||
| Q1 25 | -79.9% | 27.5% | ||
| Q4 24 | -91.8% | 27.5% | ||
| Q3 24 | -118.9% | 37.1% | ||
| Q2 24 | -111.0% | 46.4% | ||
| Q1 24 | -180.8% | 45.9% |
| Q4 25 | -73.9% | 25.2% | ||
| Q3 25 | -93.5% | 28.7% | ||
| Q2 25 | -73.9% | 17.2% | ||
| Q1 25 | -113.2% | 19.6% | ||
| Q4 24 | -122.4% | 20.9% | ||
| Q3 24 | -32.6% | 27.7% | ||
| Q2 24 | -58.8% | 33.0% | ||
| Q1 24 | -204.5% | 32.6% |
| Q4 25 | $-0.22 | $0.18 | ||
| Q3 25 | $-0.96 | $0.23 | ||
| Q2 25 | $-0.27 | $0.13 | ||
| Q1 25 | $-0.39 | $0.16 | ||
| Q4 24 | $-0.38 | $0.14 | ||
| Q3 24 | $-0.12 | $0.22 | ||
| Q2 24 | $-0.21 | $0.25 | ||
| Q1 24 | $-0.60 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.4M | $264.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-33.9M | $139.7M |
| Total Assets | $35.3M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.4M | $264.2M | ||
| Q3 25 | $22.7M | $211.1M | ||
| Q2 25 | $26.5M | $199.5M | ||
| Q1 25 | $13.0M | $198.4M | ||
| Q4 24 | $8.5M | $216.9M | ||
| Q3 24 | $11.3M | $216.8M | ||
| Q2 24 | $16.5M | $166.3M | ||
| Q1 24 | $4.0M | $168.6M |
| Q4 25 | $-33.9M | $139.7M | ||
| Q3 25 | $-26.7M | $137.4M | ||
| Q2 25 | $-19.4M | $134.3M | ||
| Q1 25 | $-34.4M | $132.9M | ||
| Q4 24 | $-25.9M | $130.4M | ||
| Q3 24 | $-20.4M | $132.9M | ||
| Q2 24 | $-25.3M | $127.3M | ||
| Q1 24 | $-36.0M | $124.2M |
| Q4 25 | $35.3M | $1.2B | ||
| Q3 25 | $36.5M | $1.2B | ||
| Q2 25 | $41.3M | $1.2B | ||
| Q1 25 | $28.6M | $1.2B | ||
| Q4 24 | $24.0M | $1.2B | ||
| Q3 24 | $27.5M | $1.3B | ||
| Q2 24 | $32.4M | $1.2B | ||
| Q1 24 | $17.9M | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $22.1M |
| Free Cash FlowOCF − Capex | $-2.5M | $19.8M |
| FCF MarginFCF / Revenue | -19.1% | 146.0% |
| Capex IntensityCapex / Revenue | 0.3% | 16.8% |
| Cash ConversionOCF / Net Profit | — | 6.46× |
| TTM Free Cash FlowTrailing 4 quarters | $-19.1M | $36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $22.1M | ||
| Q3 25 | $-3.7M | $7.0M | ||
| Q2 25 | $-7.3M | $8.7M | ||
| Q1 25 | $-4.5M | $3.0M | ||
| Q4 24 | $-5.7M | $19.6M | ||
| Q3 24 | $-10.8M | $5.4M | ||
| Q2 24 | $-13.4M | $2.3M | ||
| Q1 24 | $-10.9M | $7.4M |
| Q4 25 | $-2.5M | $19.8M | ||
| Q3 25 | $-3.9M | $6.1M | ||
| Q2 25 | $-7.4M | $8.1M | ||
| Q1 25 | $-5.3M | $2.9M | ||
| Q4 24 | $-5.8M | $18.6M | ||
| Q3 24 | $-11.0M | $5.3M | ||
| Q2 24 | $-13.5M | $2.0M | ||
| Q1 24 | $-10.9M | $7.0M |
| Q4 25 | -19.1% | 146.0% | ||
| Q3 25 | -33.9% | 43.7% | ||
| Q2 25 | -66.1% | 64.3% | ||
| Q1 25 | -57.3% | 21.2% | ||
| Q4 24 | -69.7% | 156.0% | ||
| Q3 24 | -149.9% | 38.1% | ||
| Q2 24 | -183.1% | 15.5% | ||
| Q1 24 | -169.3% | 54.8% |
| Q4 25 | 0.3% | 16.8% | ||
| Q3 25 | 1.9% | 6.0% | ||
| Q2 25 | 0.8% | 4.6% | ||
| Q1 25 | 8.2% | 0.9% | ||
| Q4 24 | 0.6% | 8.7% | ||
| Q3 24 | 2.3% | 0.7% | ||
| Q2 24 | 0.8% | 2.2% | ||
| Q1 24 | 1.0% | 3.6% |
| Q4 25 | — | 6.46× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 4.01× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 7.87× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 1.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
